Michelle T. Long

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis

Philip N. Newsome, Iris Kliers, Laura Østergaard et al. · New England Journal of Medicine · 2025 · 398 citations

AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review

Michelle T. Long, Mazen Noureddin, Joseph K. Lim · Gastroenterology · 2022 · 251 citations · Full text

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +11

Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement

Hannes Hagström, Leon A. Adams, Alina M. Allen et al. · Hepatology · 2021 · 231 citations · Full text

Bi-directional analysis between fatty liver and cardiovascular disease risk factors

Jiantao Ma, Shih‐Jen Hwang, Alison Pedley et al. · Journal of Hepatology · 2016 · 227 citations

Hyperlipidemia, Fatty Liver Disease, Obesity +16